Juno Therapeutics acquisition by Celgene
GPTKB entity
Statements (13)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:acquisition
|
| gptkbp:acquiredBy |
gptkb:Juno_Therapeutics
|
| gptkbp:acquirer |
gptkb:Celgene
|
| gptkbp:acquisition_type |
all-cash deal
|
| gptkbp:acquisition_value |
$9 billion
|
| gptkbp:announced |
2018-01-22
|
| gptkbp:completedIn |
2018-03-06
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:notableProduct |
gptkb:CAR-T_therapies
|
| gptkbp:purpose |
expand Celgene's immunotherapy portfolio
|
| gptkbp:bfsParent |
gptkb:ARCH_Venture_Partners
|
| gptkbp:bfsLayer |
6
|
| https://www.w3.org/2000/01/rdf-schema#label |
Juno Therapeutics acquisition by Celgene
|